Lung Cancer10.1016/s0169-5002(19)30249-12019127S85Treatment patterns and outcomes for limited stage small cell lung cancer treated with chemoradiotherapyD. Sim, A. Pascoe, K. Foweraker,
Annals of Oncology10.1093/annonc/mdy445.007201829ix141Chemotherapy versus combined chemoradiotherapy: Survival patterns among elderly patients with limited stage small cell lung cancerS. Abdulaziz,,
Lung Cancer10.1016/0169-5002(96)85954-x1996141175Early alternating chemotheapy and radiotherapy schedule in limited disease stage small cell lung cancer,
Lung Cancer10.1016/s0169-5002(03)92025-3200341S105P-56 Early concurrent normo- and hyperfractionated chemoradiotherapy in limited small cell lung cancer (LSCLC). Experience with 34 treated patientsZdenek Skacel, Miloslav Marel, Roman Pajdlhauser, Bela Malinova, Jana Prausova, Katerina Kosatova,
Cancer Immunology, Immunotherapy10.1007/s00262-021-02929-0202170102877-2879Correction to: Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited‑stage small cell lung cancerYamei Chen, Ying Jin, Xiao Hu, Ming Chen,,
Lung Cancer10.1016/0169-5002(94)91712-4199410S338-S339Delayed chest irradiation for patients with limited stage (LS) small cell lung cancer (SCLC),
British Journal of Cancer10.1038/s41416-020-01070-62020123S110-17Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancerJohn Conibear,,,
Community Oncology10.1016/s1548-5315(11)70578-2201078362-365Concurrent chemoradiotherapy for the synchronous presentation of limited-stage small cell and early-stage non-small cell lung cancersJohn M. Watkins, Michael A. Yehl, David Holloman, Anand K. Sharma,
Lung Cancer10.1016/s0169-5002(97)83929-3199718112Chemoradiotherapy for stage III non-small cell lung cancerEverett E. Vokes,
Lung Cancer10.1007/0-387-22652-4_102003186-206Treatment of Limited-Stage Small Cell Lung CancerRitsuko Komaki